Who is sponsoring NCT03053336?

NCT03053336 is sponsored by Karolinska Institutet.

What drugs are being tested in NCT03053336?

Interventions in NCT03053336: App-technology to increase physical activity.

What condition does NCT03053336 study?

NCT03053336 studies Type 2 Diabetes Mellitus, Exercise.

Is NCT03053336 still recruiting?

NCT03053336 is currently completed. Last updated 29 September 2020.

Last reviewed 2020-09-29 · How we verify

NCT03053336

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

App-technology to Increase Physical Activity Among Patients With Type 2 Diabetes

Completed NA Last updated 29 September 2020

What this trial tests

NA trial testing App-technology to increase physical activity in Type 2 Diabetes Mellitus in 181 participants. Completed in 30 June 2019.

Timeline

21 February 2017

Primary endpoint
30 June 2019

30 June 2019

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	181
Start date	21 February 2017
Primary completion	30 June 2019
Estimated completion	30 June 2019
Sites	1 location across Sweden

Drugs / interventions tested

App-technology to increase physical activity

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Exercise — all drugs for Exercise →

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Type 2 Diabetes Mellitus or Exercise. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of using new app-based technology to improve self-care, compared to usual care in patients with type 2 diabetes. The hypothesis is that the intervention, i.e. using the new technology, will have a greater positive effect on physical activity levels and outcomes of HbA1c than usual care.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

App-technology to increase physical activity among patients with diabetes type 2 - the DiaCert-study, a randomized controlled trial.
Bonn SE, Alexandrou C, Hjörleifsdottir Steiner K, Wiklander K, et al · · 2018 · cited 29× · PMID 29316905 · DOI 10.1186/s12889-018-5026-4
Dietary habits after a physical activity mHealth intervention: a randomized controlled trial.
Sjöblom L, Bonn SE, Alexandrou C, Dahlgren A, et al · · 2023 · cited 5× · PMID 36732788 · DOI 10.1186/s40795-023-00682-4
Effectiveness of a Smartphone App to Promote Physical Activity Among Persons With Type 2 Diabetes: Randomized Controlled Trial.
Bonn SE, Hummel M, Peveri G, Eke H, et al · · 2024 · cited 4× · PMID 38512333 · DOI 10.2196/53054
The effect of the smartphone app DiaCert on health related quality of life in patients with type 2 diabetes: results from a randomized controlled trial.
Hummel M, Bonn SE, Trolle Lagerros Y. · · 2022 · cited 2× · PMID 36528609 · DOI 10.1186/s13098-022-00965-z

Verify or expand the search:

Other trials of App-technology to increase physical activity

Trials testing the same drug.

NCT03480464 — App-technology to Improve the Level of Physical Activity After Bariatric Surgery · NA · completed

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03053336 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 29 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03053336.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing